BUDGET IMPACT OF NEWLY APPROVED DRUGS BY THE SICILIAN DRUG FORMULARY COMMITTEE: AN INTRODUCTIVE ANALYSIS

被引：0
|
作者：
Aiello, A. [1 ]
D'Ausilio, A. [1 ]
Pizzimenti, V [2 ]
Formica, D. [2 ]
Sultana, J. [2 ]
Lucchesi, S. [3 ]
Ientile, V [2 ]
Toumi, M. [4 ]
Trifiro, G. [3 ]
机构：
[1] Creativ Ceut, Milan, Italy
[2] AOU Policlin G Martino, Messina, Italy
[3] Univ Messina, Messina, Italy
[4] Aix Marseille Univ, Marseille, France
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.1631
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP97
引用
收藏
页码：A669 / A669
页数：1
相关论文
共 50 条
  • [1] AN INTRODUCTIVE ANALYSIS OF THE TIMEFRAME FROM EUROPEAN DRUGS APPROVAL TO THE SICILIAN HOSPITAL FORMULARY INCLUSION
    Aiello, A.
    D'Ausilio, A.
    Pizzimenti, V
    Formica, D.
    Sultana, J.
    Lucchesi, S.
    Ientile, V
    Toumi, M.
    Trifiro, G.
    VALUE IN HEALTH, 2017, 20 (09) : A666 - A666
  • [2] BUDGET IMPACT OF METHYLNALTREXONE SC ON A PUBLIC DRUG PROGRAM FORMULARY
    Wang, M.
    Iyer, S.
    Jeddi, M.
    VALUE IN HEALTH, 2008, 11 (06) : A519 - A519
  • [3] BUDGET IMPACT OF ANTIMALARIA DRUG FORMULARY DECISIONS: A RETROSPECTIVE ANALYSIS FROM A NIGERIAN TEACHING HOSPITAL
    Udezi, W. A.
    Usifoh, C. O.
    Omotayo, O. A.
    VALUE IN HEALTH, 2009, 12 (03) : A111 - A111
  • [4] Radiotherapy and newly approved cancer drugs - A quantitative analysis of registered protocols for drugs approved for the treatment of solid tumors
    Rabe, Leonie
    Wenz, Frederik
    Ehmann, Michael
    Lohr, Frank
    Hofheinz, Ralf Dieter
    Buergy, Daniel
    RADIOTHERAPY AND ONCOLOGY, 2022, 168 : 69 - 74
  • [5] BUDGET IMPACT ANALYSIS OF INTRODUCTION FLUTICASONE PROPIONATE/SALMETEROL (500/50 MG) INTO THE BRAZILIAN NATIONAL DRUG FORMULARY
    Godoy, M. R.
    Bueno, R. L. P.
    VALUE IN HEALTH, 2009, 12 (07) : A525 - A525
  • [6] COST-EFFECTIVENESS AND BUDGET IMPACT OF INTRODUCING ROSUVASTATIN INTO THE BRAZILIAN NATIONAL DRUG FORMULARY
    Godoy, M. R.
    Bueno, R. L. P.
    VALUE IN HEALTH, 2009, 12 (07) : A486 - A487
  • [7] BUDGET IMPACT ANALYSIS OF DRUGS: SYSTEMATIC REVIEW
    Faleiros, D.
    Alvares, J.
    Almeida, A. M.
    Araujo, V. E.
    Andrade, E., I
    Acurcio, F. D.
    Guerra Junior, A. A.
    VALUE IN HEALTH, 2015, 18 (07) : A813 - A813
  • [8] BUDGET IMPACT ANALYSIS OF TWO APPROVED THERAPIES FOR IDIOPATHIC PULMONARY FIBROSIS
    Skandamis, A.
    Souliotis, K.
    Markantonis, S.
    VALUE IN HEALTH, 2018, 21 : S233 - S233
  • [9] A BUDGET IMPACT AND RETURN ON INVESTMENT ANALYSIS OF INCORPORATING DRUG - ELUTING STENTS INTO A CHINESE HOSPITAL MEDICAL DEVICE FORMULARY - A HOSPITAL PERSPECTIVE
    Tan, B.
    Fu, Y.
    Lu, Y.
    Ren, M.
    Song, Y.
    Liu, X.
    Xuan, J.
    VALUE IN HEALTH, 2020, 23 : S189 - S190
  • [10] Budget impact analysis of including biosimilar adalimumab on formulary: A United States payer perspective
    Chaplin, Stephen
    van Stiphout, Joris
    Chen, Anna
    Li, Edward
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (11): : 1226 - 1238
12345